Human mAbs could treat Lassa fever

In a paper published in Nature Medicine, researchers at the University of Texas, Tulane University and Zalgen Labs LLC (Germantown, Md.) showed that Lassa virus glycoprotein-neutralizing mAbs rescued non-human primates infected with

Read the full 329 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE